Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 KIF27 HSPA4L ABCB5 KIF21A RNF213 CHD1 FANCM HELB ACSL3 ACSL4 ATP6V1H SHOC1 KIF14 MACF1 DNAH5 ATP2B1 DNAH9 HSPA4 TOP2A TOP2B	3.83e-08	614	165	21	GO:0140657
GeneOntologyMolecularFunction	testosterone 16-alpha-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	2.20e-06	4	165	3	GO:0008390
GeneOntologyMolecularFunction	testosterone 6-beta-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	5.47e-06	5	165	3	GO:0050649
GeneOntologyMolecularFunction	vitamin D 23-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	5.47e-06	5	165	3	GO:0062179
GeneOntologyMolecularFunction	1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	5.47e-06	5	165	3	GO:0062181
GeneOntologyMolecularFunction	vitamin D3 25-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	1.09e-05	6	165	3	GO:0030343
GeneOntologyMolecularFunction	vitamin D 24-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	1.09e-05	6	165	3	GO:0070576
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF27 ABCB5 KIF21A RNF213 CHD1 FANCM HELB ATP6V1H SHOC1 KIF14 MACF1 DNAH5 ATP2B1 DNAH9	1.86e-05	441	165	14	GO:0016887
GeneOntologyMolecularFunction	vitamin D 25-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	1.89e-05	7	165	3	GO:0070643
GeneOntologyMolecularFunction	microtubule motor activity	DNHD1 KIF27 KIF21A KIF14 DNAH5 DNAH9	2.46e-05	70	165	6	GO:0003777
GeneOntologyMolecularFunction	oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor	CYP3A4 CYP3A5 CYP3A43	3.01e-05	8	165	3	GO:0033695
GeneOntologyMolecularFunction	caffeine oxidase activity	CYP3A4 CYP3A5 CYP3A43	3.01e-05	8	165	3	GO:0034875
GeneOntologyMolecularFunction	estrogen 2-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	3.01e-05	8	165	3	GO:0101021
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNHD1 HOOK3 DNAH5 DNAH9	7.88e-05	28	165	4	GO:0051959
GeneOntologyMolecularFunction	estrogen 16-alpha-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	8.71e-05	11	165	3	GO:0101020
GeneOntologyMolecularFunction	retinoic acid 4-hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	1.89e-04	14	165	3	GO:0008401
GeneOntologyMolecularFunction	palmitoyl-CoA ligase activity	ACSL3 ACSL4	2.03e-04	3	165	2	GO:0090433
GeneOntologyMolecularFunction	oxidoreductase activity, acting on CH or CH2 groups	CYP3A4 CYP3A5 CYP3A43	2.34e-04	15	165	3	GO:0016725
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNHD1 HOOK3 DNAH5 DNAH9	2.40e-04	37	165	4	GO:0045505
GeneOntologyMolecularFunction	DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity	TOP2A TOP2B	4.03e-04	4	165	2	GO:0003918
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH5 DNAH9	4.13e-04	18	165	3	GO:0008569
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNHD1 KIF27 KIF21A KIF14 DNAH5 DNAH9	4.47e-04	118	165	6	GO:0003774
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	RRAS2 KIF27 ABCB5 KIF21A RNF213 CHD1 FANCM HELB ATP6V1H SHOC1 KIF14 MACF1 DNAH5 GNL1 ATP2B1 DNAH9	7.11e-04	775	165	16	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	RRAS2 KIF27 ABCB5 KIF21A RNF213 CHD1 FANCM HELB ATP6V1H SHOC1 KIF14 MACF1 DNAH5 GNL1 ATP2B1 DNAH9	1.62e-03	839	165	16	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	RRAS2 KIF27 ABCB5 KIF21A RNF213 CHD1 FANCM HELB ATP6V1H SHOC1 KIF14 MACF1 DNAH5 GNL1 ATP2B1 DNAH9	1.64e-03	840	165	16	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	RRAS2 KIF27 ABCB5 KIF21A RNF213 CHD1 FANCM HELB ATP6V1H SHOC1 KIF14 MACF1 DNAH5 GNL1 ATP2B1 DNAH9	1.64e-03	840	165	16	GO:0016818
GeneOntologyMolecularFunction	DNA topoisomerase activity	TOP2A TOP2B	1.84e-03	8	165	2	GO:0003916
GeneOntologyMolecularFunction	aryl hydrocarbon receptor binding	ARNT ARNT2	2.35e-03	9	165	2	GO:0017162
GeneOntologyMolecularFunction	steroid hydroxylase activity	CYP3A4 CYP3A5 CYP3A43	2.75e-03	34	165	3	GO:0008395
GeneOntologyBiologicalProcess	microtubule-based movement	DNHD1 STK36 IFT140 KIF27 COPG1 KIF21A COPG2 RFX3 MAPK8IP3 SYNE2 KIF14 TEKT1 CCR6 TRAK2 DNAH5 DNAH9	1.96e-06	493	163	16	GO:0007018
GeneOntologyBiologicalProcess	alkaloid catabolic process	CYP3A4 CYP3A5 CYP3A43	4.79e-06	5	163	3	GO:0009822
GeneOntologyBiologicalProcess	microtubule-based transport	STK36 IFT140 KIF27 COPG1 COPG2 RFX3 MAPK8IP3 SYNE2 TRAK2 DNAH5 DNAH9	5.65e-06	253	163	11	GO:0099111
GeneOntologyBiologicalProcess	resolution of meiotic recombination intermediates	FANCM SHOC1 TOP2A TOP2B	1.06e-05	18	163	4	GO:0000712
GeneOntologyBiologicalProcess	microtubule-based process	ROCK2 DNHD1 STK36 IFT140 KIF27 COPG1 KIF21A COPG2 RFX3 MAPK8IP3 SPICE1 HOOK3 SYNE2 CEP135 KIF14 TEKT1 MACF1 CCR6 TRAK2 DNAH5 DNAH9 GEN1	3.17e-05	1058	163	22	GO:0007017
GeneOntologyBiologicalProcess	alkaloid metabolic process	CYP3A4 CYP3A5 CYP3A43	3.93e-05	9	163	3	GO:0009820
GeneOntologyBiologicalProcess	lipid hydroxylation	CYP3A4 CYP3A5 CYP3A43	3.93e-05	9	163	3	GO:0002933
GeneOntologyBiologicalProcess	positive regulation of single stranded viral RNA replication via double stranded DNA intermediate	TOP2A TOP2B	6.21e-05	2	163	2	GO:0045870
GeneOntologyBiologicalProcess	oxidative demethylation	CYP3A4 CYP3A5 CYP3A43	1.01e-04	12	163	3	GO:0070989
GeneOntologyBiologicalProcess	epithelial cilium movement involved in extracellular fluid movement	STK36 KIF27 RFX3 DNAH5 DNAH9	1.03e-04	59	163	5	GO:0003351
GeneOntologyBiologicalProcess	extracellular transport	STK36 KIF27 RFX3 DNAH5 DNAH9	1.30e-04	62	163	5	GO:0006858
GeneOntologyBiologicalProcess	intra-Golgi vesicle-mediated transport	COPG1 COPG2 COG8 COG6	1.63e-04	35	163	4	GO:0006891
GeneOntologyBiologicalProcess	DNA recombination	DCAF1 SLF1 FANCM HELB SHOC1 PRMT1 CCR6 MAD2L2 GEN1 TOP2A TOP2B	1.72e-04	368	163	11	GO:0006310
GeneOntologyBiologicalProcess	cilium assembly	DNHD1 STK36 IFT140 RPGRIP1L KIF27 RFX3 CC2D2B SYNE2 CEP135 TEKT1 CPLANE1 DNAH5	2.21e-04	444	163	12	GO:0060271
HumanPheno	Ventriculomegaly	CUL4B STK36 KRT5 FLNB IFT140 RRAS2 KRT14 RPGRIP1L ACADVL KIF21A RNF213 EXTL3 FANCM COG8 GPC3 COG6 FBXO28 CEP135 KIF14 MAD2L2 CPLANE1 POMK DNAH5 DNAH9 SEMA3E	1.34e-05	790	68	25	HP:0002119
Domain	Cyt_P450_E_grp-II	CYP3A4 CYP3A5 CYP3A43	6.68e-06	5	165	3	IPR002402
Domain	Cyt_P450_E_CYP3A	CYP3A4 CYP3A5 CYP3A43	1.33e-05	6	165	3	IPR008072
Domain	Prefoldin	KRT4 KRT14 KRT19 KIF21A CEP135 TRAK2	4.19e-05	72	165	6	IPR009053
Domain	Coatomer_g_Cpla	COPG1 COPG2	7.76e-05	2	165	2	IPR032154
Domain	-	TOP2A TOP2B	7.76e-05	2	165	2	3.40.50.670
Domain	DTHCT	TOP2A TOP2B	7.76e-05	2	165	2	IPR012542
Domain	DNA_gyraseB	TOP2A TOP2B	7.76e-05	2	165	2	PF00204
Domain	-	COPG1 COPG2	7.76e-05	2	165	2	2.60.40.1480
Domain	-	TOP2A TOP2B	7.76e-05	2	165	2	3.90.199.10
Domain	TopoIIA_CS	TOP2A TOP2B	7.76e-05	2	165	2	IPR018522
Domain	COP-gamma_platf	COPG1 COPG2	7.76e-05	2	165	2	PF08752
Domain	Coatomer_g_Cpla	COPG1 COPG2	7.76e-05	2	165	2	PF16381
Domain	Coatomer_gsu_app_Ig-like-sub	COPG1 COPG2	7.76e-05	2	165	2	IPR013040
Domain	Topo_IIA	TOP2A TOP2B	7.76e-05	2	165	2	IPR001241
Domain	DNA_topoisoIV	TOP2A TOP2B	7.76e-05	2	165	2	PF00521
Domain	DUF1712	CCZ1B CCZ1	7.76e-05	2	165	2	PF08217
Domain	Topo_IIA_A/C_ab	TOP2A TOP2B	7.76e-05	2	165	2	IPR013758
Domain	Topo_IIA_A_a	TOP2A TOP2B	7.76e-05	2	165	2	IPR013757
Domain	Topo_IIA_cen_dom	TOP2A TOP2B	7.76e-05	2	165	2	IPR013759
Domain	TOP4c	TOP2A TOP2B	7.76e-05	2	165	2	SM00434
Domain	TOP2c	TOP2A TOP2B	7.76e-05	2	165	2	SM00433
Domain	Topo_IIA-like_dom	TOP2A TOP2B	7.76e-05	2	165	2	IPR013760
Domain	Topo_IIA_bsu_dom2	TOP2A TOP2B	7.76e-05	2	165	2	IPR013506
Domain	DTHCT	TOP2A TOP2B	7.76e-05	2	165	2	PF08070
Domain	-	TOP2A TOP2B	7.76e-05	2	165	2	1.10.268.10
Domain	TOPRIM_C	TOP2A TOP2B	7.76e-05	2	165	2	IPR031660
Domain	TOPRIM_C	TOP2A TOP2B	7.76e-05	2	165	2	PF16898
Domain	Coatomer_gsu	COPG1 COPG2	7.76e-05	2	165	2	IPR017106
Domain	DUF1712_fun	CCZ1B CCZ1	7.76e-05	2	165	2	IPR013176
Domain	Topo_IIA_A/C	TOP2A TOP2B	7.76e-05	2	165	2	IPR002205
Domain	TOPOISOMERASE_II	TOP2A TOP2B	7.76e-05	2	165	2	PS00177
Domain	Cullin_repeat-like_dom	CUL4B CUL2 COG8	1.40e-04	12	165	3	IPR016159
Domain	Dynein_HC_stalk	DNHD1 DNAH5 DNAH9	2.29e-04	14	165	3	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH5 DNAH9	2.29e-04	14	165	3	IPR013602
Domain	DHC_N2	DNHD1 DNAH5 DNAH9	2.29e-04	14	165	3	PF08393
Domain	MT	DNHD1 DNAH5 DNAH9	2.29e-04	14	165	3	PF12777
Domain	Arg_repress_C-like	TOP2A TOP2B	2.31e-04	3	165	2	IPR024946
Domain	Synapsin_pre-ATP-grasp_dom	SYN1 SYN2	2.31e-04	3	165	2	IPR020897
Domain	Synapsin_ATP-bd_dom	SYN1 SYN2	2.31e-04	3	165	2	IPR020898
Domain	-	TOP2A TOP2B	2.31e-04	3	165	2	3.30.1360.40
Domain	SYNAPSIN_1	SYN1 SYN2	2.31e-04	3	165	2	PS00415
Domain	SYNAPSIN_2	SYN1 SYN2	2.31e-04	3	165	2	PS00416
Domain	Synapsin_C	SYN1 SYN2	2.31e-04	3	165	2	PF02750
Domain	Synapsin_N	SYN1 SYN2	2.31e-04	3	165	2	PF10581
Domain	Synapsin_CS	SYN1 SYN2	2.31e-04	3	165	2	IPR019735
Domain	Synapsin_P_site	SYN1 SYN2	2.31e-04	3	165	2	IPR019736
Domain	Synapsin	SYN1 SYN2	2.31e-04	3	165	2	PF02078
Domain	Synapsin	SYN1 SYN2	2.31e-04	3	165	2	IPR001359
Domain	CH	FLNB SYNE2 MACF1 MICAL3 ARHGEF6	2.73e-04	65	165	5	SM00033
Domain	DHC_fam	DNHD1 DNAH5 DNAH9	2.85e-04	15	165	3	IPR026983
Domain	Dynein_heavy	DNHD1 DNAH5 DNAH9	2.85e-04	15	165	3	PF03028
Domain	Dynein_heavy_dom	DNHD1 DNAH5 DNAH9	2.85e-04	15	165	3	IPR004273
Domain	CH	FLNB SYNE2 MACF1 MICAL3 ARHGEF6	3.86e-04	70	165	5	PF00307
Domain	-	FLNB SYNE2 MACF1 MICAL3 ARHGEF6	4.12e-04	71	165	5	1.10.418.10
Domain	Toprim	TOP2A TOP2B	4.60e-04	4	165	2	PF01751
Domain	Clathrin_a/coatomer_app_sub_C	COPG1 COPG2	4.60e-04	4	165	2	IPR015873
Domain	Toprim_domain	TOP2A TOP2B	4.60e-04	4	165	2	IPR006171
Domain	TOPRIM	TOP2A TOP2B	4.60e-04	4	165	2	PS50880
Domain	-	COPG1 COPG2	4.60e-04	4	165	2	3.30.310.30
Domain	CH	FLNB SYNE2 MACF1 MICAL3 ARHGEF6	4.69e-04	73	165	5	PS50021
Domain	CH-domain	FLNB SYNE2 MACF1 MICAL3 ARHGEF6	5.31e-04	75	165	5	IPR001715
Domain	ACTININ_2	FLNB SYNE2 MACF1	1.05e-03	23	165	3	PS00020
Domain	ACTININ_1	FLNB SYNE2 MACF1	1.05e-03	23	165	3	PS00019
Domain	Actinin_actin-bd_CS	FLNB SYNE2 MACF1	1.05e-03	23	165	3	IPR001589
Domain	Peptidase_M13_C	PHEX KEL	1.58e-03	7	165	2	IPR018497
Domain	Peptidase_M13	PHEX KEL	1.58e-03	7	165	2	IPR000718
Domain	Peptidase_M13_N	PHEX KEL	1.58e-03	7	165	2	PF05649
Domain	Cullin_CS	CUL4B CUL2	1.58e-03	7	165	2	IPR016157
Domain	Peptidase_M13_N	PHEX KEL	1.58e-03	7	165	2	IPR008753
Domain	CULLIN	CUL4B CUL2	1.58e-03	7	165	2	SM00182
Domain	Peptidase_M13	PHEX KEL	1.58e-03	7	165	2	PF01431
Domain	Cullin_neddylation_domain	CUL4B CUL2	2.10e-03	8	165	2	IPR019559
Domain	DHC_N1	DNAH5 DNAH9	2.10e-03	8	165	2	PF08385
Domain	Nuc_translocat	ARNT ARNT2	2.10e-03	8	165	2	IPR001067
Domain	Cullin_Nedd8	CUL4B CUL2	2.10e-03	8	165	2	PF10557
Domain	Coatomer/calthrin_app_sub_C	COPG1 COPG2	2.10e-03	8	165	2	IPR009028
Domain	Cullin_Nedd8	CUL4B CUL2	2.10e-03	8	165	2	SM00884
Domain	Dynein_heavy_dom-1	DNAH5 DNAH9	2.10e-03	8	165	2	IPR013594
Domain	Intermediate_filament_CS	KRT4 KRT5 KRT14 KRT19	2.33e-03	63	165	4	IPR018039
Domain	Cullin_homology	CUL4B CUL2	2.68e-03	9	165	2	IPR016158
Domain	Cullin	CUL4B CUL2	3.33e-03	10	165	2	PF00888
Domain	CULLIN_2	CUL4B CUL2	3.33e-03	10	165	2	PS50069
Domain	Cullin_N	CUL4B CUL2	3.33e-03	10	165	2	IPR001373
Domain	CULLIN_1	CUL4B CUL2	3.33e-03	10	165	2	PS01256
Domain	P-loop_NTPase	DNHD1 RRAS2 KIF27 ABCB5 KIF21A RNF213 CARD10 CHD1 FANCM HELB KIF14 DLG3 CARD11 DNAH5 GNL1 DNAH9	3.50e-03	848	165	16	IPR027417
Domain	IF	KRT4 KRT5 KRT14 KRT19	3.79e-03	72	165	4	PS00226
Domain	Filament	KRT4 KRT5 KRT14 KRT19	3.98e-03	73	165	4	PF00038
Domain	IF	KRT4 KRT5 KRT14 KRT19	4.60e-03	76	165	4	IPR001664
Domain	-	SKIL SP110	4.83e-03	12	165	2	3.10.390.10
Domain	Coatomer/clathrin_app_Ig-like	COPG1 COPG2	4.83e-03	12	165	2	IPR013041
Domain	-	HSPA4L HSPA4	4.83e-03	12	165	2	2.60.34.10
Domain	HSP70_peptide-bd	HSPA4L HSPA4	4.83e-03	12	165	2	IPR029047
Domain	SAND_dom-like	SKIL SP110	4.83e-03	12	165	2	IPR010919
Domain	Kinesin_motor_CS	KIF27 KIF21A KIF14	5.64e-03	41	165	3	IPR019821
Domain	-	SYN1 SYN2	5.68e-03	13	165	2	3.40.50.20
Domain	-	HSPA4L HSPA4	5.68e-03	13	165	2	1.20.1270.10
Domain	Heat_shock_70_CS	HSPA4L HSPA4	5.68e-03	13	165	2	IPR018181
Domain	HSP70_C	HSPA4L HSPA4	5.68e-03	13	165	2	IPR029048
Domain	Kinesin-like_fam	KIF27 KIF21A KIF14	6.45e-03	43	165	3	IPR027640
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DNAH9	6.58e-03	14	165	2	IPR024317
Pathway	REACTOME_XENOBIOTICS	CYP3A4 CYP3A5 CYP3A43 ARNT ARNT2	1.38e-06	23	123	5	M5372
Pathway	REACTOME_XENOBIOTICS	CYP3A4 CYP3A5 CYP3A43 ARNT ARNT2	2.15e-06	25	123	5	MM14846
Pathway	BIOCARTA_ACETAMINOPHEN_PATHWAY	CYP3A4 CYP3A5 CYP3A43	3.52e-05	8	123	3	MM1547
Pathway	KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M	CUL4B DCAF1 CCNB3	1.02e-04	11	123	3	M47573
Pathway	WP_NPHP1_DELETION_SYNDROME	FLNB RPGRIP1L MAPK3	1.02e-04	11	123	3	M48099
Pathway	REACTOME_BIOSYNTHESIS_OF_MARESINS	CYP3A4 CYP3A5 CYP3A43	1.35e-04	12	123	3	MM15616
Pathway	WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA	CUL2 DVL2 ARNT ARNT2	2.09e-04	34	123	4	M39771
Pathway	WP_OMEGA9_FATTY_ACID_SYNTHESIS	ACSL3 ACSL4 ELOVL6	2.20e-04	14	123	3	M39780
Pathway	WP_OMEGA9_FATTY_ACID_SYNTHESIS	ACSL3 ACSL4 ELOVL6	2.20e-04	14	123	3	MM15840
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	CYP3A4 CYP3A5 CYP3A43 ARNT ARNT2	2.36e-04	64	123	5	M5650
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	CYP3A4 CYP3A5 CYP3A43 ARNT ARNT2	2.72e-04	66	123	5	MM14839
Pathway	REACTOME_ATORVASTATIN_ADME	CYP3A4 CYP3A5 CYP3A43	2.73e-04	15	123	3	MM15697
Pathway	WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION	ACADVL ACSL3 ACSL4	3.34e-04	16	123	3	MM15841
Pathway	WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION	ACADVL ACSL3 ACSL4	4.03e-04	17	123	3	M39365
Pathway	REACTOME_MISCELLANEOUS_SUBSTRATES	CYP3A4 CYP3A5 CYP3A43	4.81e-04	18	123	3	MM14843
Pathway	REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 SYN1 SYN2	4.81e-04	18	123	3	MM14702
Pathway	REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA2 SYN1 SYN2	4.81e-04	18	123	3	M27043
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	CUL2 FLNB THOC7 COPG1 HSPA4L RNF213 COPG2 CARD10 TWF2 HMGCR ITPRID2 EXTL3 ADAM10 ARFGEF3 ACSL3 ATP6V1H HOOK3 COG6 SYNE2 PEX19 KIF14 PRMT1 MICAL3 CABIN1 ATP2B1 HSPA4 TOP2A TOP2B	3.37e-10	1440	168	28	30833792
Pubmed	Joint effects of inflammation and androgen metabolism on prostate cancer severity.	CYP3A4 CYP3A5 CYP3A43 MSR1	1.82e-08	7	168	4	18566991
Pubmed	Immunolocalization patterns of cytokeratins during salivary acinar cell development in mice.	KRT4 KRT5 KRT14 KRT19	1.08e-07	10	168	4	29181608
Pubmed	Liver maturation deficiency in p57(Kip2)-/- mice occurs in a hepatocytic p57(Kip2) expression-independent manner.	KRT19 CYP3A4 CYP3A5 CYP3A43	1.08e-07	10	168	4	26165599
Pubmed	Downregulation of mouse hepatic CYP3A protein by 3-methylcholanthrene does not require cytochrome P450-dependent metabolism.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	23846873
Pubmed	Regulation of the expression of two female-predominant CYP3A mRNAs (CYP3A41 and CYP3A44) in mouse liver by sex and growth hormones.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	12147261
Pubmed	Mouse liver cytochrome P-450 (P-450IIIAM1): its cDNA cloning and inducibility by dexamethasone.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	1339292
Pubmed	Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	12617959
Pubmed	Intergenic mRNA molecules resulting from trans-splicing.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	11726664
Pubmed	High fat diet induced obesity is mitigated in Cyp3a-null female mice.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	29738703
Pubmed	A novel female-specific member of the CYP3A gene subfamily in the mouse liver.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	10775455
Pubmed	Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	19226368
Pubmed	Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	19188337
Pubmed	Human gut microbiota influences drug-metabolizing enzyme hepatic Cyp3a: A human flora-associated mice study.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	37258238
Pubmed	Effect of Naringenin, Quercetin, and Sesamin on Xenobiotica-Metabolizing CYP1A and CYP3A in Mice Offspring after Maternal Exposure to Persistent Organic Pollutants.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	28567424
Pubmed	A useful model capable of predicting the clearance of cytochrome 3A4 (CYP3A4) substrates in humans: validity of CYP3A4 transgenic mice lacking their own Cyp3a enzymes.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	25005602
Pubmed	Cloning, sequencing, heterologous expression, and characterization of murine cytochrome P450 3a25*(Cyp3a25), a testosterone 6beta-hydroxylase.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	11284050
Pubmed	Collaborated regulation of female-specific murine Cyp3a41 gene expression by growth and glucocorticoid hormones.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	14733933
Pubmed	Genetic variations in androgen metabolism genes and associations with prostate cancer in South African men.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	21081028
Pubmed	Mouse cytochrome P450 (Cyp3a11): predominant expression in liver and capacity to activate aflatoxin B1.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	9143324
Pubmed	Lentiviral transgenic microRNA-based shRNA suppressed mouse cytochromosome P450 3A (CYP3A) expression in a dose-dependent and inheritable manner.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	22291988
Pubmed	CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	15548719
Pubmed	CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	21148252
Pubmed	Different diets cause alterations in the enteric environment and trigger changes in the expression of hepatic cytochrome P450 3A, a drug-metabolizing enzyme.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	23370405
Pubmed	Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	2402224
Pubmed	Genetic analysis of sensitization and tolerance to cocaine.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	7932176
Pubmed	Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism.	CYP3A4 CYP3A5 CYP3A43	1.11e-07	3	168	3	26212543
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	KRT5 KRT14 RPGRIP1L CCDC18 RNF213 COPG2 ITPRID2 SPICE1 ACSL3 ACSL4 PHKA1 PTPN14 SYNE2 CEP135 PEX19 PHLPP1 KIF14 MICAL3 MAPK3 ATP2B1	1.95e-07	1049	168	20	27880917
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	KRT5 FGFR1OP2 RPGRIP1L ACADVL HSPA4L VPS13C POLG RNF213 CCDC90B ITPRID2 ARFGEF3 ACSL3 ACSL4 PTPN14 TRABD FBXO28 SYNE2 PEX19 CCDC25 TRAK2 SUCO GNL1 GEN1 TOP2A	2.56e-07	1496	168	24	32877691
Pubmed	Hepatocyte nuclear factor 4α regulates expression of the mouse female-specific Cyp3a41 gene in the liver.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	21088200
Pubmed	Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	36050438
Pubmed	A novel form of mouse cytochrome P450 3A (Cyp3a-16). Its cDNA cloning and expression in fetal liver.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	7813478
Pubmed	Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	17975676
Pubmed	Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	31633069
Pubmed	Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	27638959
Pubmed	Humanized xenobiotic response in mice expressing nuclear receptor SXR.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	10935643
Pubmed	Knockout of mouse Cyp3a gene enhances synthesis of cholesterol and bile acid in the liver.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	23709690
Pubmed	Thalidomide-induced limb abnormalities in a humanized CYP3A mouse model.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	26903378
Pubmed	iTAG-RNA Isolates Cell-Specific Transcriptional Responses to Environmental Stimuli and Identifies an RNA-Based Endocrine Axis.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	32130917
Pubmed	CYP3A4 and pregnane X receptor humanized mice.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	17936928
Pubmed	Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	12958193
Pubmed	Cytokeratin expression during mouse embryonic and early postnatal mammary gland development.	KRT5 KRT14 KRT19	4.41e-07	4	168	3	19937336
Pubmed	Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	10230766
Pubmed	Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	25319358
Pubmed	The transcription factor E4bp4 regulates the expression and activity of Cyp3a11 in mice.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	30796914
Pubmed	Mouse aortic muscle cells respond to oxygen following cytochrome P450 3A13 gene transfer.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	23656416
Pubmed	Molecular cloning and functional expression of a mouse cytochrome P-450 (Cyp3a-13): examination of Cyp3a-13 enzyme to activate aflatoxin B1 (AFB1).	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	7803471
Pubmed	A map of the mouse Cyp3a locus.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	14509827
Pubmed	Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans.	CYP3A4 CYP3A5 CYP3A43	4.41e-07	4	168	3	23125282
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ROCK2 EFCAB5 KRT5 FLNB KRT14 ACADVL KRT19 HSPA4L PPFIA2 ABCB5 KIF21A SIK1 PHEX ACSL3 ACSL4 CEP112 SYNE2 MACF1 DLG3 CADPS2 ATP2B1 TOP2A TOP2B	5.17e-07	1442	168	23	35575683
Pubmed	Sterol 27-hydroxylase gene dosage and the antiatherosclerotic effect of Rifampicin in mice.	CYP3A4 CYP3A5 CYP3A43	1.10e-06	5	168	3	29191818
Pubmed	Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene.	CYP3A4 CYP3A5 CYP3A43	1.10e-06	5	168	3	11266076
Pubmed	Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.	CYP3A4 CYP3A5 CYP3A43	1.10e-06	5	168	3	19920203
Pubmed	Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures.	CYP3A4 CYP3A5 CYP3A43	1.10e-06	5	168	3	29125184
Pubmed	P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.	CYP3A4 CYP3A5 CYP3A43	1.10e-06	5	168	3	23090875
Pubmed	Multiple cytochrome P450 isozymes in murine skin: induction of P450 1A, 2B, 2E, and 3A by dexamethasone.	CYP3A4 CYP3A5 CYP3A43	1.10e-06	5	168	3	8006463
Pubmed	Glycine N-methyltransferase inhibits aristolochic acid nephropathy by increasing CYP3A44 and decreasing NQO1 expression in female mouse hepatocytes.	CYP3A4 CYP3A5 CYP3A43	1.10e-06	5	168	3	29725048
Pubmed	Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes.	CYP3A4 CYP3A5 CYP3A43	1.10e-06	5	168	3	18156313
Pubmed	OATP1A/1B, CYP3A, ABCB1, and ABCG2 limit oral availability of the NTRK inhibitor larotrectinib, while ABCB1 and ABCG2 also restrict its brain accumulation.	CYP3A4 CYP3A5 CYP3A43	1.10e-06	5	168	3	32087611
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KRT5 THOC7 KRT14 RPGRIP1L KRT19 ZNF507 TWF2 ITPRID2 ARFGEF3 ARNT PTPN14 KIF14 MACF1 MAD2L2	1.16e-06	588	168	14	38580884
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	CUL4B DOCK2 DCAF1 ROCK2 FLNB COPG2 HELB DNAH9 DCAF4	1.70e-06	226	168	9	31452512
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ROCK2 KRT5 FLNB KRT14 KRT19 HSPA4L PPFIA2 ARHGEF12 TWF2 NT5DC3 MAPK8IP3 ATP6V1H SYN1 SYN2 KCNQ3 MACF1 DLG3 MICAL3 LRRC7 MAPK3 ATP2B1 HSPA4	1.71e-06	1431	168	22	37142655
Pubmed	Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol.	CYP3A4 CYP3A5 CYP3A43	2.19e-06	6	168	3	8043019
Pubmed	Defining Human Pathways of Drug Metabolism In Vivo through the Development of a Multiple Humanized Mouse Model.	CYP3A4 CYP3A5 CYP3A43	2.19e-06	6	168	3	26265742
Pubmed	Cytochrome P-450 3A13 and endothelin jointly mediate ductus arteriosus constriction to oxygen in mice.	CYP3A4 CYP3A5 CYP3A43	2.19e-06	6	168	3	21193583
Pubmed	Activated sterol regulatory element-binding protein-2 suppresses hepatocyte nuclear factor-4-mediated Cyp3a11 expression in mouse liver.	CYP3A4 CYP3A5 CYP3A43	2.19e-06	6	168	3	20926756
Pubmed	Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel.	CYP3A4 CYP3A5 CYP3A43	2.19e-06	6	168	3	21351274
Pubmed	Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice.	CYP3A4 CYP3A5 CYP3A43	2.19e-06	6	168	3	22503787
Pubmed	Upregulation of CYP2e1 and CYP3a activities in histamine-deficient histidine decarboxylase gene targeted mice.	CYP3A4 CYP3A5 CYP3A43	2.19e-06	6	168	3	14642533
Pubmed	LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver.	CYP3A4 CYP3A5 CYP3A43	2.19e-06	6	168	3	15930522
Pubmed	Specific 3-O-sulfated heparan sulfate domains regulate salivary gland basement membrane metabolism and epithelial differentiation.	KRT5 KRT14 KRT19 GPC3 FGF7 MAPK3	2.79e-06	81	168	6	39217171
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	CUL4B DOCK2 KRT5 FLNB COPG1 ACADVL KRT19 RNF213 COPG2 ACSL3 FBXO28 KIF14 MACF1 PRMT1 MAPK3 TOP2A	3.75e-06	844	168	16	25963833
Pubmed	The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons.	CYP3A4 CYP3A5 CYP3A43	3.82e-06	7	168	3	11137287
Pubmed	Cyp3a deficiency enhances androgen receptor activity and cholesterol synthesis in the mouse prostate.	CYP3A4 CYP3A5 CYP3A43	3.82e-06	7	168	3	27137100
Pubmed	Effects of infection of MRSA on the expression and activity of renal cytochrome P450s in mice.	CYP3A4 CYP3A5 CYP3A43	3.82e-06	7	168	3	30944282
Pubmed	Distinct stem cells contribute to mammary gland development and maintenance.	KRT5 KRT14 KRT19	3.82e-06	7	168	3	21983963
Pubmed	Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.	CYP3A4 CYP3A5 CYP3A43	3.82e-06	7	168	3	27514509
Pubmed	A novel transmembrane MSP-containing protein that plays a role in right ventricle development.	CYP3A4 CYP3A5 CYP3A43	3.82e-06	7	168	3	15533722
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	RPGRIP1L CCDC18 ARHGEF12 SPICE1 ARFGEF3 PHKA1 PTPN14 SYNE2 KIF14	4.01e-06	251	168	9	29778605
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ITPRID2 MAPK8IP3 COG6 SYNE2 ARNT2 PHLPP1	4.24e-06	87	168	6	12465718
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CUL4B KRT5 RPGRIP1L KRT19 VPS13C ZNF507 DVL2 ATP6V1H PTPN14 HOOK3 CEP135 KIF14 MICAL3 CPLANE1 FHIP1A TOP2A	4.29e-06	853	168	16	28718761
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	DCAF1 ROCK2 CUL2 FLNB RRAS2 COPG1 HSPA4L CHD1 TYK2 ACSL3 ATP6V1H PTPN14 PEX19 PRMT1 MAPK3 ATP2B1 HSPA4	5.50e-06	974	168	17	28675297
Pubmed	Identification and characterization of human FNBP3 gene in silico.	CYP3A4 CYP3A5 CYP3A43	6.09e-06	8	168	3	12964049
Pubmed	Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.	CYP3A4 CYP3A5 CYP3A43	6.09e-06	8	168	3	18488193
Pubmed	Lessons from keratin transgenic and knockout mice.	KRT5 KRT14 KRT19	6.09e-06	8	168	3	9932492
Pubmed	Intestinal cytochrome P450 3A plays an important role in the regulation of detoxifying systems in the liver.	CYP3A4 CYP3A5 CYP3A43	6.09e-06	8	168	3	18794335
Pubmed	An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical Trials.	CYP3A4 CYP3A5 CYP3A43	6.09e-06	8	168	3	30910785
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	ROCK2 CUL2 FLNB HSPA4L KIF21A DVL2 ACSL3 SYNE2 SYN1 MACF1 GNL1 TOP2A	6.12e-06	498	168	12	36634849
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	CUL4B CUL2 EFCAB5 FLNB RRAS2 COPG1 HSPA4L COPG2 ACSL3 ACSL4 ATP6V1H TRABD PRMT1 MAPK3 ATP2B1 HSPA4	6.16e-06	878	168	16	37223481
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	RRAS2 HSPA4L PPFIA2 MAPK8IP3 SYN1 SYN2 MACF1 MICAL3 LRRC7 JPH3	8.01e-06	347	168	10	17114649
Pubmed	Molecular Characterization of the Genital Organizer: Gene Expression Profile of the Mouse Urethral Plate Epithelium.	KRT19 CYP3A4 CYP3A5 CYP3A43	8.45e-06	27	168	4	27173853
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CUL4B DCAF1 IFT140 DVL2 L1TD1 RNF213 C16orf96 SKIL SP110 TYK2 PTPN14 ZNHIT6 CCNB3 TRABD TEKT1 MACF1 TOP2A UNC80	8.46e-06	1116	168	18	31753913
Pubmed	Type II keratins precede type I keratins during early embryonic development.	KRT5 KRT14 KRT19	9.10e-06	9	168	3	16180309
Pubmed	Identification of genetic variants associated with response to statin therapy.	CYP3A4 CYP3A5 HMGCR	9.10e-06	9	168	3	19667110
Pubmed	Chromosomal assignments of genes coding for components of the mixed-function oxidase system in mice. Genetic localization of the cytochrome P-450PCN and P-450PB gene families and the nadph-cytochrome P-450 oxidoreductase and epoxide hydratase genes.	CYP3A4 CYP3A5 CYP3A43	9.10e-06	9	168	3	3917435
Pubmed	Family-based genome-wide association scan of attention-deficit/hyperactivity disorder.	SLC9A9 CEP112 ELOVL6	9.10e-06	9	168	3	20732626
Pubmed	The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.	CYP3A4 CYP3A5 CYP3A43	9.10e-06	9	168	3	7678494
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	IFT140 TWF2 RFX3 FREM2 CPLANE1 DNAH5	9.51e-06	100	168	6	25807483
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ROCK2 FLNB HSPA4L DVL2 ARHGEF12 COPG2 SPICE1 ATP6V1H MACF1 PRMT1 MICAL3 LRRC7 ATP2B1 HSPA4	9.72e-06	708	168	14	39231216
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	KRT5 FLNB RRAS2 KRT14 ACADVL CHD1 ITPRID2 ACSL3 HOOK3 SYNE2 KIF14 MACF1 PRMT1 ATP2B1 HSPA4 TOP2A TOP2B	1.05e-05	1024	168	17	24711643
Interaction	PXN interactions	CCDC18 DVL2 ARHGEF12 ADAM10 NT5DC3 SPICE1 ARNT PTPN14 KIF14 MACF1 MAPK3 HSPA4 ARHGEF6	4.18e-06	334	166	13	int:PXN
Interaction	SPAG5 interactions	RPGRIP1L KRT19 SPICE1 HOOK3 COG6 FBXO28 ARNT2 PHLPP1 KIF14 IQCE	5.14e-06	195	166	10	int:SPAG5
Cytoband	7q21.1	CYP3A4 CYP3A5 CYP3A43	2.66e-06	8	168	3	7q21.1
GeneFamily	Cytochrome P450 family 3	CYP3A4 CYP3A5 CYP3A43	1.30e-05	8	113	3	1002
GeneFamily	Synapsins	SYN1 SYN2	1.16e-04	3	113	2	1325
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	CARD10 DLG3 CARD11	5.57e-04	26	113	3	904
GeneFamily	Topoisomerases	TOP2A TOP2B	5.71e-04	6	113	2	1050
GeneFamily	Components of oligomeric golgi complex	COG8 COG6	1.06e-03	8	113	2	493
GeneFamily	Cullins	CUL4B CUL2	1.06e-03	8	113	2	1032
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RPGRIP1L INPP4B CADPS2	1.46e-03	36	113	3	823
GeneFamily	PDZ domain containing	DVL2 ARHGEF12 DLG3 CARD11 LRRC7	2.66e-03	152	113	5	1220
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF27 KIF21A KIF14	2.97e-03	46	113	3	622
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	TYK2 PTPN14 FRMD6	3.76e-03	50	113	3	1293
GeneFamily	X-linked mental retardation\|Angiotensin receptors	ACSL4 DLG3 ARHGEF6	4.44e-03	53	113	3	103
GeneFamily	Dyneins, axonemal	DNAH5 DNAH9	4.95e-03	17	113	2	536
GeneFamily	Heat shock 70kDa proteins	HSPA4L HSPA4	4.95e-03	17	113	2	583
GeneFamily	Basic helix-loop-helix proteins	OLIG3 ARNT ARNT2 OLIG2	5.02e-03	110	113	4	420
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	DCAF1 DCAF4	5.55e-03	18	113	2	498
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ROCK2 CUL2 FLNB RRAS2 CHD1 ADAM10 ACSL3 ACSL4 ATP6V1H ELL2 SYNE2 ARNT2 CEP135 PHLPP1 KIF14 MACF1 MICAL3 SUCO ATP2B1 TOP2A	6.56e-07	856	168	20	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	KRT14 PPFIA2 KIF21A MFSD6 SYT6 ITGA8 ARHGEF12 NT5DC3 MSR1 ARFGEF3 ACSL4 FRY ARNT2 KCNN3 SYN2 KCNQ3 DLG3 MICAL3 LRRC7 ATP2B1 CCDC144A JPH3 SEMA3E	6.79e-07	1106	168	23	M39071
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	GPX3 ITGA8 ARHGEF12 RFX3 CEP112 SLCO2A1 MACF1 CADPS2	2.99e-06	137	168	8	M39241
Coexpression	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	FGFR1OP2 SLF1 KRT19 CCDC18 SIK1 SKIL SPICE1 SHOC1 GEN1	4.96e-06	195	168	9	M13736
Coexpression	SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN	CYP3A4 CYP3A5 CYP3A43 SLCO2A1	7.28e-06	20	168	4	MM1104
Coexpression	GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN	POLG ARHGEF12 ITPRID2 SKIL FRMD6 KCNN3 CADPS2 SEMA3E	4.52e-05	199	168	8	M3912
Coexpression	GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP	HSPA4L NT5DC3 ANGPTL1 AXDND1 FRMD6 DLG3 CCR6 DNAH5	4.52e-05	199	168	8	M5692
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	ROCK2 FLNB RRAS2 CHD1 ADAM10 ACSL3 CEP135 PHLPP1 KIF14 MICAL3 ATP2B1 TOP2A	5.02e-05	466	168	12	M13522
Coexpression	INAMURA_LUNG_CANCER_SCC_UP	KRT5 KRT14 TOP2A	7.06e-05	13	168	3	M1253
Coexpression	BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS	KRT5 KRT14 KRT19 SYNE2 TOP2A	8.81e-05	70	168	5	M40002
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CUL4B CUL2 SLF1 HSPA4L VPS13C L1TD1 CHD1 COG6 CEP112 SYNE2 KIF14 CPLANE1 SUCO TOP2B	8.99e-05	656	168	14	M18979
Coexpression	GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	DPY19L3 VPS13C CC2D2B ELL2 PHLPP1 ATP2B1 TOP2A	9.75e-05	165	168	7	M337
Coexpression	LIN_MELANOMA_COPY_NUMBER_UP	POLG RNF213 COPG2 ARNT DNAH5	1.01e-04	72	168	5	M346
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	IFT140 POLG FRY CEP135 MACF1 MICAL3 CABIN1	1.01e-04	166	168	7	M6826
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	CUL4B CCZ1B FLNB THOC7 CCDC90B SIK1 HMGCR ADAM10 SP110 COG8 CCNG1 ACSL3 ACSL4 ZNHIT6 CCZ1 SYNE2 MACF1 OTULINL HSPA4 IQCE	1.07e-04	1215	168	20	M41122
Coexpression	GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	TRPM6 DPY19L3 TTBK1 SYNE2 MACF1 OTULINL ELOVL6	1.13e-04	169	168	7	M6700
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	ROCK2 VPS13C POLG KIF21A CCDC18 CHD1 FANCM RFX3 ACSL4 CEP135 SYN1 KIF14 MICAL3 GEN1 HSPA4	1.47e-05	532	162	15	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ROCK2 HSPA4L KIF21A CCDC18 DVL2 CHD1 ADAM10 ACSL4 FREM2 SYNE2 CEP135 SYN1 KCNN3 PHLPP1 CCDC25 MICAL3 OLIG2 ATP2B1 GEN1 HSPA4 TOP2B	2.15e-05	989	162	21	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MROH9 SLC9A9 SYT6 ITGA8 MSR1 PHEX GPC3 MACF1 FGF7 CADPS2 SEMA3E	2.16e-10	194	168	11	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	RRAS2 KIF21A RFX3 ARFGEF3 KLRF1 SYNE2 CARD11 DNAH5 DNAH9 TOP2A	2.71e-09	188	168	10	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MROH9 SLC9A9 ITGA8 MSR1 PHEX GPC3 MACF1 FGF7 CADPS2 SEMA3E	3.49e-09	193	168	10	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	MS-CD8-proli_CD4\|MS / Condition, Cell_class and T cell subcluster	FLNB RPGRIP1L FANCM ZFY SPICE1 HELB ARNT2 MICAL3 CABIN1	1.98e-08	172	168	9	0b6dd257110b3f17fa71ab18a165b091a9d5ae9a
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	RRAS2 KRT19 ARHGEF12 ARFGEF3 FREM2 SYNE2 ROS1 CADPS2 FHIP1A	5.12e-08	192	168	9	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	KRT19 ARHGEF12 ARFGEF3 CEP112 SYNE2 TEKT1 CADPS2 DNAH5 DNAH9	5.85e-08	195	168	9	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	KRT19 ARHGEF12 ARFGEF3 CEP112 SYNE2 TEKT1 CADPS2 DNAH5 DNAH9	5.85e-08	195	168	9	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	KRT19 ARHGEF12 ARFGEF3 SYNE2 TEKT1 MACF1 DNAH5 DNAH9 TOP2A	6.12e-08	196	168	9	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	KRT19 ARHGEF12 ARFGEF3 SYNE2 TEKT1 MACF1 DNAH5 DNAH9 TOP2A	6.12e-08	196	168	9	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	KRT19 KIF21A ARFGEF3 ACSL4 TRABD SYNE2 GALNT5 CADPS2 FHIP1A	6.39e-08	197	168	9	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLF1 PPFIA2 COPG2 FRY SYN2 KCNQ3 LRRC7 ATP2B1 UNC80	6.67e-08	198	168	9	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RNF213 CHD1 INPP4B HELB SYNE2 MACF1 PCNX1 CCDC144A	2.93e-07	171	168	8	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	FNIP2 ARFGEF3 FREM2 KCNQ3 ROS1 CADPS2 DNAH5 FHIP1A	4.51e-07	181	168	8	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 VPS13C SIK1 CHD1 MSR1 MACF1 ATP2B1 TOP2B	4.71e-07	182	168	8	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 PPFIA2 ARFGEF3 FREM2 ROS1 DNAH5 DNAH9 UNC80	5.11e-07	184	168	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 PPFIA2 ARFGEF3 FREM2 ROS1 DNAH5 DNAH9 UNC80	5.11e-07	184	168	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 PPFIA2 ARFGEF3 FREM2 ROS1 DNAH5 DNAH9 UNC80	5.11e-07	184	168	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 KIF27 FREM2 FRMD6 TEKT1 DNAH5 DNAH9 FHIP1A	5.33e-07	185	168	8	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RIN3 ITGA8 INPP4B MSR1 FGF7 LRRC7 CABIN1 SEMA3E	5.33e-07	185	168	8	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 VPS13C SIK1 CHD1 MSR1 MACF1 ATP2B1 TOP2B	5.33e-07	185	168	8	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	PND14-Epithelial-Epithelial_Airway\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF27 KRT19 HSPA4L KIF21A TEKT1 DNAH5 DNAH9 SEMA3E	5.78e-07	187	168	8	1399c703505211c510b3f14c7a2aa9930566c473
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	6.02e-07	188	168	8	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RPGRIP1L KIF27 KRT19 HSPA4L KIF21A TEKT1 OSCP1 DNAH5	6.26e-07	189	168	8	fa1ff8b7fa53f3148d9117d6e598097f03af5eb2
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	ROCK2 FLNB PPFIA2 ITGA8 NT5DC3 INPP4B FRY MACF1	6.26e-07	189	168	8	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RPGRIP1L KIF27 KRT19 HSPA4L KIF21A TEKT1 OSCP1 DNAH5	6.26e-07	189	168	8	565063f9e3dd79164321f8a394bd12c176baf202
ToppCell	PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RPGRIP1L KIF27 KRT19 HSPA4L KIF21A TEKT1 OSCP1 DNAH5	6.26e-07	189	168	8	497be236848ebf5ad75d1f0c71e6261f5d3521da
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	6.78e-07	191	168	8	a05e9a7eb137d804570dd7d8905975d735738767
ToppCell	PND07-Epithelial-Epithelial_Airway\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KRT4 KRT5 KRT14 KRT19 HSPA4L C16orf96 TEKT1 DNAH5	6.78e-07	191	168	8	b55500eb416f4f339031acad16b2737e5b891d8e
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RRAS2 GPX3 ITGA8 PHEX GPC3 MACF1 FGF7 MICAL3	7.05e-07	192	168	8	2802fae55683345ff94a1ecf73b6fbee4f17481e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARFGEF3 ACSL4 FREM2 KCNQ3 ROS1 CADPS2 DNAH5 FHIP1A	7.05e-07	192	168	8	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.05e-07	192	168	8	0afb9dbe468e0be442c326e11c5fc0f699b32f23
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.05e-07	192	168	8	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.05e-07	192	168	8	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	FNIP2 INPP4B ARFGEF3 PTPN14 CADPS2 DNAH5 FHIP1A SEMA3E	7.34e-07	193	168	8	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.34e-07	193	168	8	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.34e-07	193	168	8	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	cbe518b465b4ef32797ae6b608219207c08493df
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	b616ee6f1d878935d293c8e0a8bbc5b4385301f0
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	PND10-Mesenchymal-Mesenchymal_structural\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	11d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	RRAS2 KRT19 ARHGEF12 ARFGEF3 SYNE2 ROS1 CADPS2 FHIP1A	7.93e-07	195	168	8	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	PND07-Mesenchymal-Mesenchymal_structural\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	2f9a274b26fc528a85f50933ec2f4db1dc9da0ca
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	RRAS2 KRT19 ARHGEF12 ARFGEF3 SYNE2 ROS1 CADPS2 FHIP1A	7.93e-07	195	168	8	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	PND03-Mesenchymal-Mesenchymal_structural\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	136b06b0931a69b1241101f68c01c44c70365fd9
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	7.93e-07	195	168	8	10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 VPS13C GPX3 TMOD4 CHD1 ANGPTL1 ACSL3 CEP112	7.93e-07	195	168	8	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	8.24e-07	196	168	8	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 GPX3 ITGA8 BRINP1 PHEX GPC3 MACF1 FGF7	8.24e-07	196	168	8	2a885eed52f9b002c7995e11e450c7e8d7ae69e6
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RPGRIP1L KIF27 RFX3 SYNE2 KCNN3 CPLANE1 DNAH5 DNAH9	8.56e-07	197	168	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNB INPP4B ARFGEF3 PTPN14 SYNE2 DNAH5 FHIP1A SEMA3E	8.89e-07	198	168	8	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	STK36 KIF27 TEKT1 OSCP1 DNAH5 DNAH9 IQCE SEMA3E	8.89e-07	198	168	8	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SERPINA3 GPX3 ITGA8 ANGPTL1 PHEX GPC3 MACF1 FGF7	8.89e-07	198	168	8	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SERPINA3 CYP3A5 GPX3 ITGA8 PHEX GPC3 MACF1 FGF7	9.24e-07	199	168	8	7f4840ae6a888380feca722543e5e52783f3e35d
ToppCell	proximal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SERPINA3 CYP3A5 GPX3 ITGA8 PHEX GPC3 MACF1 FGF7	9.24e-07	199	168	8	301d02bbb37e6f1d24b6e865bc3fe3e91260eb30
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SERPINA3 CYP3A5 GPX3 ITGA8 PHEX GPC3 MACF1 FGF7	9.24e-07	199	168	8	9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	KRT4 SERPINA3 KRT19 SYT6 ARFGEF3 FREM2 TEKT1 DNAH5	9.24e-07	199	168	8	8649c2380285a668782d75eb076ce548eed0911d
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROCK2 FLNB ARHGEF12 RNF213 ITPRID2 SYNE2 MACF1 MAPK3	9.59e-07	200	168	8	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	SLF1 COPG2 FRY SYN2 KCNQ3 LRRC7 ATP2B1 UNC80	9.59e-07	200	168	8	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROCK2 FLNB ARHGEF12 RNF213 ITPRID2 SYNE2 MACF1 MAPK3	9.59e-07	200	168	8	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROCK2 FLNB SLF1 ARHGEF12 RNF213 ITPRID2 SYNE2 MACF1	9.59e-07	200	168	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	RNF213 CHD1 INPP4B HELB SYNE2 MACF1 PCNX1	2.18e-06	156	168	7	1545169694f686d28648a68b552c2ae606599d66
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC9A9 RIN3 TLR10 FRY CARD11 OTULINL ARHGEF6	3.29e-06	166	168	7	63dc58864268b4e7779e4c45155022556fc634f9
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCDC18 ITGA8 GPC3 CEP112 KIF14 GEN1 TOP2A	3.70e-06	169	168	7	563c267edaade0e5df192ad953801ef9768d4270
ToppCell	LPS-antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PPFIA2 ANGPTL1 TLR10 CARD11 CCR6 GEN1	4.49e-06	174	168	7	9eb3504f9340517ef5d056503044fbdb9ffeb714
ToppCell	LPS-antiTNF-Lymphocytic_B\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PPFIA2 ANGPTL1 TLR10 CARD11 CCR6 GEN1	4.49e-06	174	168	7	cc493654ea3517bc6a145c7f787f304929636f86
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RRAS2 GPX3 ITGA8 PHEX GPC3 MACF1 FGF7	4.49e-06	174	168	7	3c47d069bd836599a8d40eae485c23d4d3487517
ToppCell	LPS-antiTNF-Lymphocytic_B-B_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PPFIA2 ANGPTL1 TLR10 CARD11 CCR6 GEN1	4.49e-06	174	168	7	b4c2d1c029fcd0d4926aa79a5b789c713919dcf3
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAS2 TMOD4 PHEX GPC3 MACF1 KEL GALNT5	4.84e-06	176	168	7	d30241fb8119834d6e7b59efec3f92fc7a3d1247
ToppCell	COVID-19-B_cells-Activated_B_cells\|COVID-19 / group, cell type (main and fine annotations)	DOCK2 SP110 ANGPTL1 TLR10 CARD11 MICAL3 ATP2B1	5.02e-06	177	168	7	653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIF21A ARFGEF3 ACSL4 SYNE2 GALNT5 CADPS2 FHIP1A	5.40e-06	179	168	7	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	MatrixFB-Fibroblast-A\|MatrixFB / shred on cell class and cell subclass (v4)	RRAS2 VPS13C GPX3 BRINP1 PHEX GPC3 MACF1	5.61e-06	180	168	7	adc64ad6033af705dd7b9163a83e20ef5c59f6eb
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KRT4 FLNB INPP4B ARFGEF3 PTPN14 DNAH5 SEMA3E	6.03e-06	182	168	7	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KRT19 KIF21A ACSL4 ROS1 GALNT5 CADPS2 FHIP1A	6.03e-06	182	168	7	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARHGEF12 FREM2 PTPN14 CADPS2 DNAH5 FHIP1A SEMA3E	6.47e-06	184	168	7	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIF21A ARFGEF3 ACSL4 ROS1 GALNT5 CADPS2 FHIP1A	6.47e-06	184	168	7	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	IPF-Epithelial-ATII\|IPF / Disease state, Lineage and Cell class	KRT19 ARFGEF3 FREM2 KCNQ3 ROS1 CADPS2 FHIP1A	6.71e-06	185	168	7	563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	GPX3 ITGA8 INPP4B MSR1 FGF7 UNC80 SEMA3E	6.71e-06	185	168	7	9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	KRT19 ARFGEF3 FREM2 KCNQ3 ROS1 CADPS2 FHIP1A	6.95e-06	186	168	7	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIF21A ARFGEF3 ACSL4 ROS1 GALNT5 CADPS2 FHIP1A	6.95e-06	186	168	7	e83718fabb057100835d3357df407f283d23fe16
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPGRIP1L KIF27 KIF21A TEKT1 DNAH5 DNAH9 SEMA3E	7.20e-06	187	168	7	04dba2ed09ee4180830bdf0191921696697ea234
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SLC9A9 ITGA8 INPP4B MSR1 FGF7 UNC80 SEMA3E	7.20e-06	187	168	7	13731298bc562ec29582f5da1b4c97261284f6f1
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	DOCK2 INPP4B HELB KLRF1 SYNE2 PCNX1 CARD11	7.20e-06	187	168	7	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPGRIP1L KIF27 KIF21A TEKT1 DNAH5 DNAH9 SEMA3E	7.20e-06	187	168	7	805dafe22f835ece4dd091d8030d0a63b52a48dd
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	TRPM6 KRT5 KRT19 ARFGEF3 PTPN14 DNAH5 FHIP1A	7.20e-06	187	168	7	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	P15-Mesenchymal\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RRAS2 GPX3 ITGA8 GPC3 MACF1 FGF7 OTULINL	7.45e-06	188	168	7	f1ba0b661621a65c91432e62ba73531bdf18e7c1
ToppCell	Epithelial-Epithelial-D_(Ciliated)\|Epithelial / shred on cell class and cell subclass (v4)	RPGRIP1L SLF1 KIF27 HSPA4L TEKT1 DNAH5 DNAH9	7.45e-06	188	168	7	8f30535a32968a81a304315a49c0d90a77d36948
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	VPS13C RNF213 CHD1 SYNE2 MACF1 PCNX1 SUCO	7.45e-06	188	168	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF27 HSPA4L KIF21A C16orf96 TEKT1 DNAH5 DNAH9	7.71e-06	189	168	7	02c6128a9ab5818e0881dcadafdad5f08b9a67cf
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF27 HSPA4L KIF21A C16orf96 TEKT1 DNAH5 DNAH9	7.71e-06	189	168	7	164ea92ff6a1aa2ead1c9b8f64f99a9d65437232
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 PTPN14 SYNE2 ARNT2 MICAL3 DNAH5 FHIP1A	7.71e-06	189	168	7	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	PND10-Epithelial-Epithelial_Airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF27 KRT19 HSPA4L KIF21A TEKT1 DNAH5 DNAH9	7.71e-06	189	168	7	407d8a59969d83f014600aae1a55092283a13970
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACSL4 PTPN14 SYNE2 ARNT2 MICAL3 DNAH5 FHIP1A	7.71e-06	189	168	7	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	KRT19 ARFGEF3 FREM2 KCNQ3 ROS1 CADPS2 FHIP1A	7.98e-06	190	168	7	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF27 HSPA4L KIF21A TEKT1 DNAH5 DNAH9 SEMA3E	7.98e-06	190	168	7	35248a8be476ea8d06d67c3d98a25be1f7c150b7
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF27 HSPA4L KIF21A TEKT1 DNAH5 DNAH9 SEMA3E	7.98e-06	190	168	7	5f5206f9e725070d865f4c891ff08bb750e58582
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	FNIP2 RRAS2 ARHGEF12 MAPK8IP3 ELL2 MICAL3 FHIP1A	7.98e-06	190	168	7	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF27 HSPA4L KIF21A TEKT1 DNAH5 DNAH9 SEMA3E	7.98e-06	190	168	7	088e3f39a1e5e11354d6e7458e8e6a39f14936b3
Computational	Genes in the cancer module 68.	KRT4 KRT5 KRT14 KRT19	9.73e-05	26	102	4	MODULE_68
Computational	Keratin.	KRT4 KRT5 KRT14 KRT19	9.73e-05	26	102	4	MODULE_298
Drug	obeticholic acid	RRAS2 CYP3A4 CYP3A5 CYP3A43 GPX3 HMGCR TYK2 ACSL4 PRMT1 ROS1 MAPK3 ELOVL6	1.28e-06	283	167	12	ctd:C464660
Drug	olomoucine II	KRT4 KRT5 KRT14 KRT19 HSPA4	1.42e-06	27	167	5	CID005494414
Drug	eucalyptol	CYP3A4 CYP3A5 HMGCR	1.54e-06	4	167	3	ctd:C010087
Drug	azidopine	CYP3A4 CYP3A5 ABCB5 CABIN1 TOP2B	1.71e-06	28	167	5	CID000656406
Drug	naphthoquinone	SERPINA3 CYP3A4 CYP3A5 HMGCR MAPK3 ELOVL6 TOP2B	2.04e-06	80	167	7	CID000008530
Drug	Velcade (bortezomib	KRT4 KRT5 KRT14 KRT19 CYP3A4 CYP3A5 CCNG1 CCNB3 FGF7 CCR6 MAPK3 HSPA4 TOP2B	4.13e-06	374	167	13	CID000093860
Drug	AC1L1SX8	CYP3A4 CYP3A5 CYP3A43 ABCB5	7.89e-06	18	167	4	CID000060278
Drug	lovastatin acid	CYP3A4 ABCB5 HMGCR SYNE2	1.23e-05	20	167	4	CID000064727
Drug	Digocin	CYP3A4 CYP3A5 ABCB5 HMGCR SLCO2A1 TOP2B	1.27e-05	70	167	6	CID000003062
Drug	4-phenylbutyl isothiocyanate	CYP3A4 CYP3A5 MAPK3	1.33e-05	7	167	3	CID000124881
Drug	pyrazoloacridine	ABCB5 EXTL3 FGF7 TOP2B	1.84e-05	22	167	4	CID005351360
Drug	tBCEU	CYP3A5 ABCB5 TOP2B	2.11e-05	8	167	3	CID000164059
Drug	R7 1	CYP3A4 CYP3A5 HMGCR	2.11e-05	8	167	3	CID000001949
Drug	OC144-093	CYP3A4 ABCB5 KEL	2.11e-05	8	167	3	CID006450807
Drug	probenecid	CYP3A4 CYP3A5 ABCB5 SLCO2A1 KEL OSCP1 TOP2B	3.50e-05	123	167	7	CID000004911
Drug	AC1NOLIT	CYP3A4 CYP3A5 MAPK3	4.48e-05	10	167	3	CID005090286
Drug	AC1L2XOG	CYP3A4 CYP3A5 ABCB5	4.48e-05	10	167	3	CID000130599
Drug	alternariol monomethyl ether	ARNT TOP2A TOP2B	4.48e-05	10	167	3	ctd:C018206
Drug	Epirubicin	CHD1 TOP2A	5.35e-05	2	167	2	DB00445
Drug	4-hydroxymidazolam	CYP3A4 CYP3A5	5.35e-05	2	167	2	ctd:C042940
Drug	Dexrazoxane	TOP2A TOP2B	5.35e-05	2	167	2	DB00380
Drug	norverapamil	CYP3A4 CYP3A5	5.35e-05	2	167	2	ctd:C016904
Drug	5,6-dihydro-2H-pyran-2-one	CYP3A4 CYP3A5	5.35e-05	2	167	2	CID000520660
Drug	notopterol	CYP3A4 CYP3A5	5.35e-05	2	167	2	CID005320227
Drug	N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide	CYP3A4 CYP3A5	5.35e-05	2	167	2	ctd:C114289
Drug	F14512	TOP2A TOP2B	5.35e-05	2	167	2	ctd:C534191
Drug	Daunorubicin	TOP2A TOP2B	5.35e-05	2	167	2	DB00694
Drug	6 beta-hydroxytestosterone	CYP3A4 CYP3A5	5.35e-05	2	167	2	ctd:C025591
Drug	CQA 206-291	CYP3A4 CYP3A5	5.35e-05	2	167	2	ctd:C059483
Drug	fructus schizandrae, radix ginseng, radix ophiopogonis drug combination	CYP3A4 CYP3A5	5.35e-05	2	167	2	ctd:C009252
Drug	SR-12813	CYP3A4 CYP3A5 ABCB5 HMGCR	5.75e-05	29	167	4	CID000446313
Drug	ellipticine	CYP3A4 MAPK3 TOP2A TOP2B	5.75e-05	29	167	4	ctd:C034192
Drug	bifonazole	CYP3A4 CYP3A5 HMGCR	6.12e-05	11	167	3	CID000002378
Drug	AC1L7R8G	CYP3A4 CYP3A5 POLG	8.12e-05	12	167	3	CID000315219
Drug	7-hydroxyellipticine	CYP3A4 CYP3A5 TOP2B	8.12e-05	12	167	3	CID000125663
Drug	1,3-dimethylpurine-2,6,8-trione	CYP3A4 CYP3A5 KEL	8.12e-05	12	167	3	CID014754220
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	CUL2 FLNB VPS13C POLG ADAM10 SYNE2 MACF1 MICAL3	8.61e-05	191	167	8	4168_DN
Drug	4-Aminopyridine	SYN1 GALNT5 MAPK3 JPH3	9.68e-05	33	167	4	ctd:D015761
Drug	diflomotecan	CYP3A4 CYP3A5 ABCB5 FGF7	9.68e-05	33	167	4	CID000219023
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A	CUL4B DCAF1 KRT4 IFT140 MAPK8IP3 PCNX1 ARHGEF6 IQCE	9.94e-05	195	167	8	6215_UP
Drug	Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A	RIN3 RPGRIP1L CYP3A4 SIK1 SKIL ADAM10 MAPK8IP3 TRABD	9.94e-05	195	167	8	2776_DN
Drug	Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A	ROCK2 CYP3A5 ARHGEF12 MAPK8IP3 SLCO2A1 MACF1 DCAF4 IQCE	9.94e-05	195	167	8	2394_UP
Drug	6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A	FLNB ITPRID2 SKIL ADAM10 FRY TRABD MACF1 PCNX1	1.03e-04	196	167	8	2511_DN
Drug	THDCA	CYP3A4 CYP3A5 ABCB5	1.05e-04	13	167	3	CID000119046
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; PC3; HT_HG-U133A	IFT140 CYP3A5 ITGA8 BRINP1 SP110 MAPK8IP3 PHEX ARNT	1.11e-04	198	167	8	3749_UP
Drug	PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A	ITGA8 MAPK8IP3 KLRF1 PRDM11 GPC3 SLCO2A1 ELOVL6 CADPS2	1.18e-04	200	167	8	3776_UP
Drug	AC1L85AO	CYP3A4 CYP3A5 ABCB5 CABIN1 TOP2B	1.24e-04	66	167	5	CID000372705
Drug	Tetracycline	TRPM6 SERPINA3 ACADVL CYP3A4 ABCB5 GPX3 DVL2 HMGCR TYK2 CCNG1 ARNT CCNB3 MAPK3 ELOVL6 TOP2A	1.26e-04	668	167	15	ctd:D013752
Drug	9-hydroxyellipticine	CYP3A4 CYP3A5 TOP2B	1.33e-04	14	167	3	CID000091643
Drug	AD 288	ABCB5 MAPK3 TOP2B	1.33e-04	14	167	3	CID000073553
Drug	troglitazone	CYP3A4 HSPA4L CYP3A5 ABCB5 MSR1 CCNG1 ACSL4 CCNB3 FGF7 MAPK3 ELOVL6 HSPA4 TOP2B	1.42e-04	526	167	13	CID000005591
Drug	hypericin	CYP3A4 CYP3A5 CYP3A43 ABCB5 PHEX MAPK3	1.47e-04	108	167	6	CID005281051
Drug	satraplatin	CYP3A4 EXTL3 FGF7 CABIN1	1.53e-04	37	167	4	CID006918220
Drug	erythralosamine	CYP3A4 CYP3A5	1.60e-04	3	167	2	CID000352196
Drug	3-methoxymorphinan	CYP3A4 CYP3A5	1.60e-04	3	167	2	ctd:C028657
Drug	fluoroanilinoazatoxin	ABCB5 TOP2B	1.60e-04	3	167	2	CID000378896
Drug	dechloroethylcyclophosphamide	CYP3A4 CYP3A5	1.60e-04	3	167	2	ctd:C064445
Drug	6 beta-hydroxydexamethasone	CYP3A4 CYP3A5	1.60e-04	3	167	2	CID000063050
Drug	territrem C	CYP3A4 CYP3A5	1.60e-04	3	167	2	CID000160306
Drug	NSC688503	ABCB5 TOP2B	1.60e-04	3	167	2	CID000390744
Drug	Cp-100356	CYP3A4 ABCB5	1.60e-04	3	167	2	CID000196918
Drug	BIBW22BS	ABCB5 TOP2B	1.60e-04	3	167	2	CID000132088
Drug	tryptophan ethyl ester	KRT4 KRT5	1.60e-04	3	167	2	CID000081996
Drug	R101933	CYP3A4 ABCB5	1.60e-04	3	167	2	CID000219080
Drug	hispidulin	SYN1 MAPK3	1.60e-04	3	167	2	ctd:C055957
Drug	methylazatoxin	ABCB5 TOP2B	1.60e-04	3	167	2	CID000148162
Drug	1-hydroxymethylmidazolam	CYP3A4 CYP3A5	1.60e-04	3	167	2	ctd:C040081
Drug	9-hydroxyellipticine	CYP3A4 TOP2A	1.60e-04	3	167	2	ctd:C008009
Drug	Wp159	ABCB5 TOP2B	1.60e-04	3	167	2	CID003060549
Drug	N-acetyl-S-pentachloro-1,3-butadienylcysteine	CYP3A4 CYP3A5	1.60e-04	3	167	2	ctd:C049739
Disease	non-syndromic X-linked intellectual disability (implicated_via_orthology)	ACSL3 ACSL4 DLG3	1.38e-05	9	164	3	DOID:0050776 (implicated_via_orthology)
Disease	Epidermolysis bullosa simplex 1A, generalized severe	KRT5 KRT14	3.07e-05	2	164	2	cv:C0079295
Disease	Epidermolysis bullosa simplex	KRT5 KRT14	3.07e-05	2	164	2	cv:C0079298
Disease	Epidermolysis bullosa simplex with mottled pigmentation	KRT5 KRT14	3.07e-05	2	164	2	C0432316
Disease	epidermolysis bullosa simplex Dowling-Meara type (implicated_via_orthology)	KRT5 KRT14	3.07e-05	2	164	2	DOID:0060735 (implicated_via_orthology)
Disease	EPIDERMOLYSIS BULLOSA SIMPLEX 1A, GENERALIZED SEVERE	KRT5 KRT14	3.07e-05	2	164	2	131760
Disease	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1	KRT5 KRT14	3.07e-05	2	164	2	C3715082
Disease	B cell deficiency (implicated_via_orthology)	TOP2A TOP2B	3.07e-05	2	164	2	DOID:2115 (implicated_via_orthology)
Disease	non-syndromic X-linked intellectual disability 63 (implicated_via_orthology)	ACSL3 ACSL4	3.07e-05	2	164	2	DOID:0112050 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	KRT5 FLNB KRT14 CYP3A4 EFCAB13 ADAM10 SP110 INPP4B PTPN14 HOOK3 SPATA21 SYNE2 MACF1 LRRC7 GALNT5 DNAH9 GEN1 TOP2A	3.20e-05	1074	164	18	C0006142
Disease	Mental Retardation, X-Linked Nonsyndromic	ACSL4 DLG3 ARHGEF6	4.63e-05	13	164	3	C3501611
Disease	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE (disorder)	KRT5 KRT14	9.18e-05	3	164	2	C1832926
Disease	Epidermolysis Bullosa Herpetiformis Dowling-Meara	KRT5 KRT14	9.18e-05	3	164	2	C0079295
Disease	Epidermolysis Bullosa Simplex Kobner	KRT5 KRT14	9.18e-05	3	164	2	C0079299
Disease	Weber-Cockayne Syndrome	KRT5 KRT14	9.18e-05	3	164	2	C0080333
Disease	Primary Ciliary Dyskinesia	STK36 RPGRIP1L DNAH5 DNAH9	1.36e-04	47	164	4	C4551720
Disease	metabolonic lactone sulfate measurement	CYP3A4 CYP3A5 CYP3A43	1.53e-04	19	164	3	EFO_0800659
Disease	hydrocephalus (implicated_via_orthology)	STK36 KIF27 POMK	1.53e-04	19	164	3	DOID:10908 (implicated_via_orthology)
Disease	Dowling-Degos disease 1	KRT5 ADAM10	1.83e-04	4	164	2	C4552092
Disease	non-obstructive coronary artery disease	PHLPP1 ATP2B1	1.83e-04	4	164	2	EFO_1001483
Disease	Reticulate acropigmentation of Kitamura	KRT5 ADAM10	1.83e-04	4	164	2	C0406811
Disease	tacrolimus measurement	CYP3A4 CYP3A5	1.83e-04	4	164	2	EFO_0008458
Disease	Epidermolysis Bullosa	KRT5 KRT14	1.83e-04	4	164	2	C0014527
Disease	autism spectrum disorder (implicated_via_orthology)	SLC9A9 CHD1 BRINP1 SYN1 SYN2 CADPS2	2.14e-04	152	164	6	DOID:0060041 (implicated_via_orthology)
Disease	dowling-degos disease	KRT5 ADAM10	3.04e-04	5	164	2	C3714534
Disease	Epidermolysis Bullosa Simplex	KRT5 KRT14	3.04e-04	5	164	2	C0079298
Disease	cerebellar ataxia (is_implicated_in)	RPGRIP1L POLG	3.04e-04	5	164	2	DOID:0050753 (is_implicated_in)
Disease	Congenital muscular dystrophy (disorder)	SYNE2 POMK	4.54e-04	6	164	2	C0699743
Disease	Sjogren-Larsson syndrome (implicated_via_orthology)	ACSL3 ACSL4	4.54e-04	6	164	2	DOID:14501 (implicated_via_orthology)
Disease	Ischemic stroke	TMOD4 MSR1 TTBK1 ZNHIT6 ARNT2 PCNX1 ATP2B1 JPH3	4.81e-04	324	164	8	HP_0002140
Disease	Polydactyly	IFT140 RPGRIP1L FREM2 GPC3 CPLANE1	5.06e-04	117	164	5	C0152427
Disease	intellectual disability (is_implicated_in)	RPGRIP1L ACSL4 ARHGEF6	6.13e-04	30	164	3	DOID:1059 (is_implicated_in)
Disease	epidermolysis bullosa simplex (is_implicated_in)	KRT5 KRT14	6.33e-04	7	164	2	DOID:4644 (is_implicated_in)
Disease	Large cell carcinoma of lung	TRPM6 TTBK1 ROS1	7.43e-04	32	164	3	C0345958
Disease	Mental Retardation, X-Linked 1	ACSL4 DLG3 ARHGEF6	7.43e-04	32	164	3	C2931498
Disease	eosinophil percentage of leukocytes	CUL2 RIN3 KIF27 CCDC18 C16orf96 CHD1 COG6 TRABD CARD11 OTULINL OLIG2 DCAF4	9.92e-04	746	164	12	EFO_0007991
Disease	adult respiratory distress syndrome (implicated_via_orthology)	SERPINA3 HSPA4	1.08e-03	9	164	2	DOID:11394 (implicated_via_orthology)
Disease	lung cancer (is_marker_for)	GPX3 CCNG1 ACSL3	1.33e-03	39	164	3	DOID:1324 (is_marker_for)
Disease	ciliopathy (implicated_via_orthology)	RPGRIP1L CC2D2B TEKT1	1.43e-03	40	164	3	DOID:0060340 (implicated_via_orthology)
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	RRAS2 HMGCR ADAM10 TRABD SYNE2 MACF1	1.63e-03	224	164	6	EFO_0004530, EFO_0008317
Disease	endometrial carcinoma, endometriosis	TLR10 CEP112	1.63e-03	11	164	2	EFO_0001065, EFO_1001512
Disease	Barrett's esophagus (is_implicated_in)	GPX3 MSR1	1.63e-03	11	164	2	DOID:9206 (is_implicated_in)
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	HOOK3 SYNE2	1.95e-03	12	164	2	DOID:11726 (implicated_via_orthology)
Disease	methionine sulfone measurement	CYP3A4 CYP3A43	1.95e-03	12	164	2	EFO_0800072
Disease	acute myeloid leukemia (implicated_via_orthology)	TOP2A TOP2B	1.95e-03	12	164	2	DOID:9119 (implicated_via_orthology)
Disease	Colorectal Carcinoma	ABCB5 CHD1 BRINP1 ACSL4 GMCL2 ARNT ZNHIT6 CCNB3 SLCO2A1 DLG3 JPH3	1.97e-03	702	164	11	C0009402
Disease	severe acute respiratory syndrome (is_marker_for)	SERPINA3 MSR1 FGF7	2.28e-03	47	164	3	DOID:2945 (is_marker_for)
Disease	Prostatic Neoplasms	SERPINA3 CYP3A4 CYP3A5 CYP3A43 GPX3 CHD1 MSR1 ACSL4 MAPK3 TOP2A	2.43e-03	616	164	10	C0033578
Disease	Malignant neoplasm of prostate	SERPINA3 CYP3A4 CYP3A5 CYP3A43 GPX3 CHD1 MSR1 ACSL4 MAPK3 TOP2A	2.43e-03	616	164	10	C0376358
Disease	urate measurement, bone density	TRPM6 PPFIA2 ABCB5 CCNG1 KIF14 CADPS2 CABIN1 OLIG2 DNAH9 JPH3	2.52e-03	619	164	10	EFO_0003923, EFO_0004531
Disease	hepatocellular carcinoma (implicated_via_orthology)	POLG CCNG1 GPC3	2.57e-03	49	164	3	DOID:684 (implicated_via_orthology)
Disease	unipolar depression, anxiety	BRINP1 LRRC7	2.67e-03	14	164	2	EFO_0003761, EFO_0005230
Disease	Hermansky-Pudlak syndrome (implicated_via_orthology)	CCZ1B CCZ1	2.67e-03	14	164	2	DOID:3753 (implicated_via_orthology)
Disease	ovarian carcinoma (is_implicated_in)	CCNG1 CABIN1	3.07e-03	15	164	2	DOID:4001 (is_implicated_in)
Disease	Situs ambiguus	DNAH5 DNAH9	3.07e-03	15	164	2	C0266642
Disease	Metastatic melanoma	ROCK2 SIK1 TTBK1	3.40e-03	54	164	3	C0278883
Disease	thyroid volume	FGF7 DNAH5	3.50e-03	16	164	2	EFO_0004865
Disease	FEV/FEC ratio	EFCAB5 VPS13C ITGA8 BRINP1 INPP4B FREM2 SYNE2 KCNN3 MICAL3 MAPK3 DNAH5 ATP2B1 HSPA4 TOP2B JPH3	3.63e-03	1228	164	15	EFO_0004713
Disease	pneumonia, COVID-19	COPG1 CARD11 UNC80 IQCE	3.70e-03	113	164	4	EFO_0003106, MONDO_0100096
Disease	eosinophil count	CUL2 RIN3 KIF27 ABCB5 CCDC18 C16orf96 CHD1 COG6 TRABD SYN2 PCNX1 CARD11 CCR6 OTULINL OLIG2 HSPA4 DCAF4	3.92e-03	1488	164	17	EFO_0004842
Disease	cancer (implicated_via_orthology)	FRMD6 MACF1 DLG3 MAPK3 TOP2A TOP2B	3.96e-03	268	164	6	DOID:162 (implicated_via_orthology)
Disease	neuroblastoma	DOCK2 KRT5 L1TD1 DNAH5	4.07e-03	116	164	4	EFO_0000621
Disease	serum non-albumin protein measurement	EFCAB13 SP110 ARNT ELL2 PHLPP1 CARD11 CCR6	4.19e-03	361	164	7	EFO_0004568
Disease	drug-Induced dyskinesia, response to levodopa	EXTL3 ADAM10	4.43e-03	18	164	2	EFO_0010747, EFO_1000904
Disease	Meckel syndrome type 1	RPGRIP1L KIF14	4.43e-03	18	164	2	C3714506
Disease	rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement	TYK2 COG6 CCR6	5.24e-03	63	164	3	EFO_0000685, EFO_0007791, EFO_0009459
Disease	chronic obstructive pulmonary disease	EFCAB5 RIN3 ITGA8 PRDM11 SYN2 MICAL3 DNAH5 HSPA4 DCAF4 TOP2B	5.29e-03	688	164	10	EFO_0000341
Disease	Familial aplasia of the vermis	RPGRIP1L CPLANE1	5.46e-03	20	164	2	cv:C0431399

Protein segments in the cluster

Peptide	Gene	Start	Entry
EIMDRIYKNVMSKVQ	ACSL4	376	O60488
RRNKMTAYITELSDM	ARNT	101	P27540
VRILQDEQYLMASDM	DCAF4	376	Q8WV16
NYMIAMRLAQLSEEK	CARD10	206	Q9BWT7
YQMTRERMTQAEEES	ELL2	131	O00472
KEERYLMLFSNVLIM	ARHGEF6	466	Q15052
TDIQIMEYTLANMAK	BRINP1	281	O60477
IKDLDSQTMMVLVNY	SERPINA3	196	P01011
RMRKYQMTGVEEVTQ	ADAM10	181	O14672
VQMEYLDMVVNETLR	CYP3A5	351	P20815
TREKAFEQMYEEMLQ	ABCB5	891	Q2M3G0
NVKMDILSYMRRQAA	GPX3	206	P22352
KARSMTDVYLLNMAI	CCR6	76	P51684
EDTNVRLNKMESEYM	CEP112	386	Q8N8E3
RLNKMESEYMAQTQS	CEP112	391	Q8N8E3
KESRNMNSRVTQLYM	ANGPTL1	121	O95841
QEVVNLKSYMERNML	CCDC144CP	986	Q8IYA2
ESMKTINLLQRMNIY	DPY19L3	121	Q6ZPD9
LDSQVMTALKMERYL	DNHD1	276	Q96M86
RVTDMFTDQEKQLME	CCDC90B	176	Q9GZT6
DNIYINIFDEMMTEK	CC2D2B	966	Q6DHV5
EQILRMEMSALQKQY	CHD1	711	O14646
SQMVRMLDILAEYLK	CHD1	811	O14646
MSLNIITVTLNMEKY	DVL2	261	O14641
TMNRMTVVQAYINEK	ATP2B1	481	P20020
VEEDKSSTMQYVILM	ARHGEF12	536	Q9NZN5
MLKDEVRTLTYRNSM	PRMT1	66	Q99873
LTDYMNRQIEITSDM	CCNB3	1146	Q8WWL7
RNKMTQYITELSDMV	ARNT2	76	Q9HBZ2
KTTNLEEMRIAMETY	IQCE	241	Q6IPM2
QYRFTVSDLMRMEKI	CCNG1	126	P51959
MMFYIDLKQTNDVLL	DCAF1	356	Q9Y4B6
QLSEMLLYMIKEGTT	KIF14	811	Q15058
KLVTVDTTMYEMQAL	OR10A7	186	Q8NGE5
AKILSDMRSQYEVMA	KRT19	246	P08727
VQEKNAMVRYESELM	MICAL3	1901	Q7RTP6
TMTSDILKMQLYVEE	MAD2L2	191	Q9UI95
REMLNLYIENEGKMI	HSPA4	591	P34932
MIQTYVEHIERSKMQ	MAPK8IP3	171	Q9UPT6
YQMEVEAVTRKMENL	RPGRIP1L	526	Q68CZ1
MLVYLDMSKNRIETV	LRRC7	231	Q96NW7
KMEEKYQLTARLNME	GPC3	76	P51654
SRILNEMRDQYEKMA	KRT14	281	P02533
YLSKMISMDIEQVIT	HMGCR	311	P04035
YLALDNKMIVEMLRT	PHKA1	531	P46020
NKMIVEMLRTDLSYL	PHKA1	536	P46020
QMVNMYQDILTELSK	INPP4B	306	O15327
MARLLREYQELMNTK	KRT5	446	P13647
DMLSRIKYLQTRIDM	KCNQ3	556	O43525
INDSEMRAIYMKSLR	FANCM	1556	Q8IYD8
NMIAEMQLTKAIVYI	FREM2	2346	Q5SZK8
MQLTKAIVYIEEMSS	FREM2	2351	Q5SZK8
ARMLREYQELMSVKL	KRT4	416	P19013
LQMEYLDMVVNETLR	CYP3A4	351	P08684
RIDIQMKNRMDGTYA	FLNB	691	O75369
QLYNEEMKMKVLERD	KIF27	1131	Q86VH2
VMDDGTNEYKIIMLN	PCNX1	1916	Q96RV3
LSKMQNVMYDLITEL	KCNN3	631	Q9UGI6
TVEKFQEEMNSYMLI	COG8	386	Q96MW5
TYEELQREMKKSLMD	POLG	451	P54098
SYEMSKEQLMSQEER	GNL1	136	P36915
TLEAMRDVYIVQDLM	MAPK3	111	P27361
MYMQNTVSLEEELRK	HOOK3	346	Q86VS8
ALYQIKEMMQLTRDN	MFSD6	701	Q6ZSS7
MSKDSSYLQERIMVI	MROH9	131	Q5TGP6
IYSLRNQEMKSAMQR	OR4D6	286	Q8NGJ1
MDLELAMLRQQTMVY	ITPRID2	976	P28290
DELRSYSSLMKVENM	CCDC25	181	Q86WR0
LSCEYKMENVTRMVV	ITGA8	711	P53708
EMASRVEQSYQKVMA	MACF1	931	Q9UPN3
RNYILMLTSSLEEMK	OLIG3	131	Q7RTU3
IMLYQVTEVYEQMKT	OTULINL	246	Q9NUU6
EERVYNVSAEIMAMK	MSR1	216	P21757
MLVSIQARSKDISYM	OR7D4	81	Q8NG98
ALELIMSKYREQMFR	FGFR1OP2	96	Q9NVK5
ETTQKARFEMVLDLM	PEX19	241	P40855
MLERFEKYMEDIQSN	CEP135	511	Q66GS9
IMEQMALLQETAYER	COG6	211	Q9Y2V7
IYITEDMLMSRKLNG	FRMD6	481	Q96NE9
MNMSVLTLQEYEFEK	ELOVL6	1	Q9H5J4
MSGYQRLMKEVTEDL	EFCAB5	231	A4FU69
IEQLKMYEMLVTQSH	FHIP1A	116	Q05DH4
MQDEERYMTLNVQSK	KLRF1	1	Q9NZS2
VERIMSETYMLIKQV	CABIN1	1881	Q9Y6J0
KEYERREDFQMQLMT	DOCK2	1366	Q92608
VQMEYLDMVVNETLR	CYP3A43	351	Q9HB55
GNQIEMMKDRYITLD	C16orf96	756	A6NNT2
SESVRQMLQDEMFKL	CPLANE1	2041	Q9H799
MESVMKEQEQYIATQ	CCDC18	1111	Q5T9S5
VIEVINDKDMSYMTV	GALNT5	616	Q7Z7M9
EDRLQEMYLKSKMLS	FNIP2	1056	Q9P278
VMLTYEREEVLMNSL	EXTL3	666	O43909
QMIDFYKDLVTQRVM	AXDND1	301	Q5T1B0
DIRYESMINTMLKDL	ARFGEF3	1551	Q5TH69
MTYLKIQSFINRMEE	CCZ1	201	P86791
VLQELRDISSMAMEY	FBXO28	196	Q9NVF7
RSQTGVQILMKIEYM	ZNHIT6	396	Q9NWK9
KNDMANMYVLLRAVS	CUL2	291	Q13617
MTYLKIQSFINRMEE	CCZ1B	201	P86790
MENMYIEELRSSVNL	CADPS2	301	Q86UW7
DQTLRRMCYLTIKEM	COPG2	81	Q9UBF2
ITDGTMLQAIERYMK	COPG2	131	Q9UBF2
MLQAIERYMKQAIVD	COPG2	136	Q9UBF2
KSIEALMEMNRRQTY	DLG3	746	Q92796
SAITREKEMLSNLYM	EFCAB13	141	Q8IY85
SYLTQMDVKLVFVME	GEN1	61	Q17RS7
ITDSTMLQAIERYMK	COPG1	131	Q9Y678
MLQAIERYMKQAIVD	COPG1	136	Q9Y678
IQMFNKDLDAVRMIY	DNAH9	571	Q9NYC9
REIYEISMQLMQILE	FRY	1271	Q5TBA9
QEVVNLKSYMERNML	CCDC144A	1176	A2RUR9
MKNNYNIMEIRTVAV	FGF7	91	P21781
STIQMLFYMEKREAL	IFT140	231	Q96RY7
YKHRMNTVMLQLEEV	CARD11	361	Q9BXL7
RQYQIDAAIVRIMKM	CUL4B	846	Q13620
LMTDLEKNALIMYSR	HELB	286	Q8NG08
LMFQRTIESYVDKRM	DNAH5	2626	Q8TE73
TEMRLVNEMYQTSLR	DNAH5	3831	Q8TE73
EEMNTKYQRDIREAM	PPFIA2	316	O75334
LQEIRTMMTQLKSYL	RIN3	641	Q8TB24
MLTVRRMELKADQLY	PDHA2	66	P29803
MDQVSLLISVMDYDR	SYT6	441	Q5T7P8
SAMLEQIAMSDRYKL	SYN1	341	P17600
SAMLEQIAMSDRYKL	SYN2	341	Q92777
KEQTVQYILTMVDDM	ATP6V1H	86	Q9UI12
TLRYGKIMIMTDQDQ	TOP2B	551	Q02880
MERQSRVMSEKDEYQ	SLC9A9	1	Q8IVB4
KNFIQLETYSEVMMV	TLR10	531	Q9BXR5
MEEVMRTYLKQQEKL	SKIL	531	P12757
MDNRNTQMYTEEEKT	SPATA21	1	Q7Z572
EESQKELESYMMRAQ	SYNE2	851	Q8WXH0
DNMVQRLETDFKMTL	RFX3	546	P48380
ELKIMNTEQYIQTMT	NT5DC3	416	Q86UY8
LFVMQVEMDVYTTLK	GMCL2	266	Q8NEA9
EDYMKRLHSMSQETI	PRDM11	261	Q9NQV5
MLREKMEYSAQLQAA	PTPN14	726	Q15678
VTYMEASAKIRMNVD	RRAS2	151	P62070
QVMETKDMLYIVTEF	SIK1B	91	A0A0B4J2F2
QVMETKDMLYIVTEF	SIK1	91	P57059
NYEKASDNIIMRLMA	SHOC1	931	Q5VXU9
NTIYIDEVLCMQMRK	TEKT1	381	Q969V4
RNYILMLTNSLEEMK	OLIG2	156	Q13516
MLVNIQTENKAISYM	OR7D2	81	Q96RA2
YQKVLDTLRDAMMSQ	POMK	331	Q9H5K3
GLLDNSIITKRMYME	SP110	36	Q9HB58
DIISTMFNRKFMEEL	OSCP1	51	Q8WVF1
ILTQAYKRMAEEAMQ	STK36	301	Q9NRP7
RLSIMKEILSDQYQM	SPICE1	91	Q8N0Z3
EKLARMVMLQYVTES	ACADVL	381	P49748
IMDRIYKNVMNKVSE	ACSL3	386	O95573
LYMMVLRVVNQEEKS	SLCO2A1	536	Q92959
MRVSTEEELKFLQMA	RNF213	3776	Q63HN8
RVEQMTKTYNDIDMV	TRAK2	101	O60296
YQLIMSVFENSMKER	TTBK1	286	Q5TCY1
KLTISNRQDELMYML	UNC80	1896	Q8N2C7
TSERVTEMYFQLKEM	TRPM6	1176	Q9BX84
LLNSYIENEGKMIMQ	HSPA4L	596	O95757
SEITRLQMELMEYKT	KIF21A	391	Q7Z4S6
ELCQYRVSMLKMDES	TRABD	106	Q9H4I3
RTSEAMYNKMNISEL	PHEX	291	P78562
MEIDMTYQLKVIQQS	ROCK2	686	O75116
MIDLLESVDYMVRNA	VPS13C	341	Q709C8
VALMETKNREGLNYM	ROS1	2261	P08922
KTLLVYDMNLREMEN	THOC7	66	Q6I9Y2
LEELSQRYRKQMEEM	SUCO	936	Q9UBS9
IAAILDMYTLMSNKQ	TMOD4	131	Q9NZQ9
GALRETMYRTQKEMQ	SLF1	236	Q9BQI6
LRYGKIMIMTDQDQD	TOP2A	531	P11388
EETLSQKRFLMNTEM	ZNF507	406	Q8TCN5
VERLQALYMIRMKDS	USP41	161	Q3LFD5
TKNEEEYMVNTFIVM	PHLPP1	1236	O60346
LKVITIYNQEMESME	SEMA3E	461	O15041
KMVNYIQMKLDLERE	TWF2	196	Q6IBS0
REKMVYMTVNDSQQE	ZFY	291	P08048
SQQMVMVKYLATLER	TYK2	251	P29597
MSQLVEEMLLKQRDF	KEL	346	P23276
LELQEEKLSNYRMEM	JPH3	601	Q8WXH2
IQDLMFEEMRETLKN	L1TD1	61	Q5T7N2